Quality | 2020.11.10
Hope Biosciences Stem Cell Research Foundation Selects Phlexglobal to Support Rapid, Compliant Investigational New Drug Application for COVID-19 Therapy
Rapidly growing research foundation replaced existing eCTD solution with PhlexSubmission to improve the speed, quality, and cost-effectiveness of submission process
(PRWeb November 10, 2020)
Read the full story at https://www.prweb.com/releases/hope_biosciences_stem_cell_research_foundation_selects_phlexglobal_to_support_rapid_compliant_investigational_new_drug_application_for_covid_19_therapy/prweb17529662.htm
For more information, please visit
https://www.prweb.com/releases/hope_bios[...]d_19_therapy/prweb17529662.htm
